Conditions: Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 20
Healthy volunteers: yes

Brief summary:
The purpose of this study is to see whether ASP-1001 when given as a nasal spray is safe and can reduce the signs and symptoms of allergic rhinitis (hayfever) following nasal challenge with antigen.

Detailed description:

Arms:
arm 1: Topical ASP-1001 arm 2: Placebo for Topical ASP-1001

Interventions: intervention 1: ASP-1001 nasal spray intervention 2: Placebo for ASP-1001
Intervention descriptions: intervention 1: 2 sprays (total 200 microliters) in each nostril 20 minutes before allergen challenge. intervention 2: 2 sprays (total 200 microliters) in each nostril 20 minutes before allergen challenge.

Protocol document: